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Hemoglobin has been encapsulated in phospholipid vesicles by extrusion of hemoglobin/lipid mixtures 
through polycarbonate membranes. This technique avoids the use of organic solvents, sonication, and 
detergents which have proven deleterious to hemoglobin. The vesicles are homogeneous, with a mean size 
of 2400 A as determined by photon correlation spectroscopy. The encapsulated hemoglobin binds oxygen 
reversibly and the vesicles are impermeable to ionic compounds. Hemoglobin encapsulated in egg 
phosphatidylcholine vesicles converts to methemoglobin within 2 days at 4°C. By contrast, when a mixture 
of dimyristoyl phosphatidylcholine, cholesterol and dicetyl phosphate is used there is no acceleration in 
methemoglobin formation, and the preparation is stable for at least 14 days at 4°C. 
Hemoglobin Phospholipid Vesicles 
1. INTRODUCTION 
Situations exist in which adequate supplies of 
blood of suitable type are not available, conse- 
quently there is an acknowledged need [l] for a 
blood surrogate. Ideally, such a fluid would bind 
oxygen cooperatively, have no toxic or antigenic 
properties and be sufficiently stable to allow the 
patient to survive until whole blood could be ad- 
ministered. Here we report on our effort to 
prepare a blood surrogate based on encapsulation 
of hemoglobin in large unilamellar phospholipid 
vesicles. Our encapsulation method follows the ex- 
trusion procedure in [2] and yields stable vesicles 
narrowly distributed in size. Our method differs in 
several significant respects from that in [3,4]. 
2. MATERIALS AND METHODS 
Egg phosphatidylcholine (EPC), dimyristoyl 
phosphatidylcholine (DMPC), and bovine brain 
phosphatidylserine (BPS) were purchased from 
Avanti Polar Lipids; horse heart cytochrome c, the 
sodium salt of diphosphoglyceric acid and tetra- 
methylenephenylenediamine from Sigma; 
cholesterol and dicetylphosphate (DCP) from 
Liposomes Encapsulation Blood 
Supelco, Inc. Hemoglobin derived from outdated 
human blood at - 150 mg/ml was supplied by 
Fisher Diagnostics. All other chemicals were 
reagent grade and used without additional 
purification. Polycarbonate membranes were ob- 
tained from Nucleopore. 
Oxygen dissociation curves were measured on an 
unmodified Aminco ‘Hem-o-Scan’. Optical spec- 
tra were measured on a Cary 219C at 20°C. Lipid 
concentration was determined as in [5]. 
Hemoglobin was assayed as the CN-met derivative 
[6]. Cytochrome c was measured spectrophoto- 
metrically taking EmM = 11.9 at 555 nm for the 
reduced protein. The photon correlation spec- 
troscopy apparatus consisted of a He-Ne laser, 
associated optics, a Malvern 48 channel correlator, 
and an Apple II microcomputer. 
Hemoglobin is encapsulated as follows: The sol- 
vent is removed with a rotary evaporator from 
75 pmol of a mixture of EPC, cholesterol and BPS 
5 : 4 : 1 or of DMPC, cholesterol and DCP 5 : 4 : 1. 
Concentrated hemoglobin (3 ml) in buffer 
(100 mM NaCl, 20 mM HEPES, 1 mM EDTA, 
pH 7.4) is added to the lipid, which is dispersed by 
vortexing. The mixture is then placed at 20°C in an 
ultra-filtration cell (Amicon Model 12) and forced 
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by argon pressure through polycarbonate mem- 
branes twice each through membranes with 
6000 A, 4000 A and 2000 A pores. The resulting 
mixture of vesicles and free hemoglobin is 
separated at 4°C on a column of Sepharose CL-6B 
(Pharmacia). The purified vesicles may then be 
concentrated on an && 100000 cut-off ultrafilter 
(Nucleopore), or by centrifugation at 5000 
rev./min for 20 min. 
Vesicle size is determined from diffusion coeffi- 
cients derived from photon correlation spec- 
troscopy on dilute suspensions of vesicles [7,8]. 
Measurements are done at a scattering angle of 90” 
for different sampling-time intervals. No laser 
heating effects were found. The hemoglobin 
molecules do not affect the time dependence of the 
correlation function for the range of sampling- 
time intervals used. 
3. RESULTS AND DISCUSSION 
Vesicles formed in hemoglobin solution from 
EPC, cholesterol and BPS elute near the void 
volume of the CLdB gel, are quite turbid and pink 
in color. When hemoglobin alone is subjected to 
extrusion and gel filtration none elutes with the 
void volume. The absorption spectrum of the vesi- 
cle hemoglobin fraction (upper trace fig.1) is that 
of oxyhemoglobin superimposed upon a steep 
background resulting from light scattering by the 
vesicles. The background may be eliminated and 
the spectra rendered more readily interpretable by 
recording the data as the first derivative (dA/dh). 
In this mode (lower trace fig. l), the LY and /3 bands 
are depicted with maxima at 582 and 548 nm and 
minima at 570 and 528 nm. Photon correlation 
spectroscopy reveals that this fraction contains 
uniform-sized vesicles of 2315 A f 52 A with a 
polydispersity of 0.066 & 0.058. The vesicles are 
stable over 50 h at 4°C in that the average size 
changes by -4% to 2407 A f 18 A, and the 
polydispersity only increases to 0.23 & 0.08. 
Co-elution of hemoglobin with the void-volume 
vesicle fraction supports either protein encapsula- 
tion, hemoglobin binding to vesicles, or formation 
of large protein aggregates. To demonstrate ex- 
plicitly-that he hemoglobin is encapsulated, an ali- 
quot of a modified Drabkin’s reagent (200 mg 
KsFe(CN)h, 50 mg KCN, 140 mg KH2P04, in 
100 ml, pH 7.4) [6] was added to a solution of 
286 
WAVELENGTH, nm 
Fig. 1. The absorption spectrum of a dilute suspension of 
vesicles containing hemoglobin, shown both as the 
absolute spectrum and in first derivative mode 
(as dA/dA). 
vesicles. Accessible hemoglobin would be con- 
verted to CN-methemoglobin, changing the ab- 
sorption spectrum. Derivative spectra of vesicle- 
encapsulated hemoglobin in the absence and 
presence of Drabkin’s reagent are compared in 
fig.2. The spectra are identical (the change in in- 
tensity in the presence of reagent is an effect of 
dilution). Adding the detergent Triton X-100 
(0.1%) lyses the vesicles resulting in immediate 
conversion of released hemoglobin to CN- 
methemoglobin as shown by the broad derivative 
band with a crossover point near 530 nm. Two 
conclusions follow from this experiment: 
(1) None of the hemoglobin is exposed on the 
vesicle surface or extends through the bilayer; 
(2) The bilayer itself is impermeable to added 
CN- and Fe(CN)e3-. 
The EPC/cholesterol/BPS vesicles maintain their 
integrity against ion permeation for at least 24 h at 
room temperature. As expected, after 24 h there is 
spectral evidence of methemoglobin formation. 
However, the CN-methemoglobin derivative is not 
formed until the vesicles are lysed with detergent. 
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F&.2. Three derivative traces of an encapsulating vesicle 
suspension of EPC/Chol/BPS: (A) pure suspension; (B) 
after addition of the modified Drabkin’s reagent; (C) 
after addition of Triton X-100. 
Vesicle integrity in the presence of hemoglobin is 
a function of the lipids used in the encapsulation. 
When hemoglobin is encapsulated using pure egg 
EPC the vesicles are leaky to Drabkin’s reagent. 
That this is related to interaction of hemoglobin 
and lipid is demonstrated by the following ex- 
periments. Oxidized cytochrome c was encap- 
sulated in EPC vesicles by the same procedure used 
for hemoglobin. Addition of sodium ascorbate 
(6 mM) to the outside of the vesicles did not pro- 
duce a spectrum of reduced cytochrome c. Subse- 
quent addition of the transmembrane electron 
transfer agent tetramethylenephenylenediamine 
resulted in rapid reduction of the cytochrome c, 
but no loss of light scattering due to the vesicles. 
Reduction was also accomplished upon treatment 
of the vesicles with Triton X-100 in the presence of 
external ascorbate. Thus EPC vesicles loaded with 
cytochrome c are impermeable to ascorbate. 
However, when an equimolar mixture of 
hemoglobin and cytochrome c was encapsulated 
and then ascorbate added, cytochrome c was im- 
mediately reduced. We conclude that pure EPC 
vesicles, which are intact when formed in the 
presence of cytochrome c, do not maintain their 
impermeability in the presence of hemoglobin. Ad- 
dition of BPS and cholesterol restores structural 
integrity to the vesicular membrane in the presence 
of a protein which otherwise renders the bilayer 
leaky. 
Oxygen dissociation measurements (fig.3) show 
very similar oxygen affinities for the precursor and 
the encapsulated hemoglobin (PRO of 9.1 and 
PO*. mm Hg 
Fig.3. Oxygenation curve of hemoglobin encapsulated in 
vesicles of EPC/Chol/BPS as determined on the Hem-o- 
Scan: temp., 2O’C; gas mixtures included carbon 
dioxide. 
11 mm Hg, respectively). Cooperativity is main- 
tained with a Hill coefficient of 3 for the precursor 
and 2.9 for the encapsulated hemoglobin. 
It is possible to calculate the trapped volume per 
lipid and thence the trapping efficiency if the lipid 
concentration and the concentrations of the 
hemoglobin before and after encapsulation are 
known: 
Trapped volume = [Hb]ri,,r/ [Hblinitiar 
Mole lipid [Lipidlfi,,r 
Using EPC/cholesterol/BPS, - 1.8 1 of the initial 
hemoglobin solution are trapped/m01 lipid. A 
theoretical trapped volume may be calculated 
assuming all vesicles are unilamellar, spherical and 
trap hemoglobin at its initial concentration. For a 
bilayer thickness of 40 A (slightly thicker than the 
pure EPC bilayer because of ordering of the 
phospholipids by cholesterol) and an area/lipid 
molecule of 48 A2 [9], trapping volume is 
-5 l/mol for vesicles of 2300 A diameter. Thus, 
the trapping efficiency for this lipid mixture is in 
the range of 35%. 
Although the vesicles described above are intact, 
oxygenate normally, and are well-characterized, 
the use of EPC presents one major problem in 
achieving the goal of a red cell surrogate - the 
stability of hemoglobin in the vesicles is diminished 
significantly compared to that in solution. The en- 
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capsulated protein converts to methemoglobin and 
further degradation products within 2 days at 4°C. 
Hemoglobin which is extruded in the absence of 
lipid or is in contact with an unextruded lipid 
dispersion retains its normal stability. Substituting 
DMPC and DCP for EPC and BPS, respectively, 
in the lipid mixture results in a profound improve- 
ment in hemoglobin stability. The vesicles 
themselves are unusually stable and resist lysis by 
Triton X-100 or other commonly available 
detergents. They may be concentrated by cen- 
trifugation and resuspended without loss of con- 
tents. While the size of these vesicles is identical to 
those formed with the unsaturated lipids, the trap- 
ping efficiency is up to 50% of the theoretical 
limit, and the hemoglobin remains stable against 
oxidation to methemoglobin for 1 14 days at 4°C. 
Our preparation compares favorably to much 
less well-defined multilamellar liposomes in which 
hemoglobin has been entrapped [3,4]. The size of 
those liposomes was presumed to range from 
0.02-l /rm. Although some cooperative 02 bind- 
ing by the hemoglobin was demonstrated, no 
estimation was given of the total amount of func- 
tional hemoglobin. 
One significant advantage of the extrusion pro- 
cedure over other methods of encapsulation is that 
it is gentle to the hemoglobin. Detergent-based 
methods, which can yield large unilamellar 
vesicles, have not been successful for hemoglobin 
encapsulation. For example, the deoxycholate- 
based method [lo] works well for cytochrome c, 
but gave low and erratic trapping for hemoglobin. 
The octylglucoside dialysis procedure [ 1 l] resulted 
in aggregation and denaturation of hemoglobin 
upon dialysis of this detergent. 
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